Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Andrade-Gordon

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|September 26, 1995
Evidence for the presence of a protease-activated receptor distinct from the thrombin receptor in human keratinocytesR J Santulli, C K Derian, A L Darrow, et al.
Bioorganic & Medicinal Chemistry Letters|August 22, 2001
Thrombin receptor (PAR-1) antagonists. Solid-phase synthesis of indole-based peptide mimetics by anchoring to a secondary amideH C Zhang, D F McComsey, K B White, et al.
Blood|November 10, 1998
Protease-activated receptor 1 (PAR-1) is required and rate-limiting for thrombin-enhanced experimental pulmonary metastasisM L Nierodzik, K Chen, K Takeshita, et al.
Bioorganic & Medicinal Chemistry Letters|September 12, 2001
1,2,4-triazolo[3,4-a]pyridine as a novel, constrained template for fibrinogen receptor (GPIIb/IIIa) antagonistsE C Lawson, W J Hoekstra, M F Addo, et al.
Archives of Biochemistry and Biophysics|May 23, 2001
Protease-activated receptor-2 (PAR-2): structure-function study of receptor activation by diverse peptides related to tethered-ligand epitopesB E Maryanoff, R J Santulli, D F McComsey, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Thrombin receptor (PAR-1) antagonists. Heterocycle-based peptidomimetics of the SFLLR agonist motifW J Hoekstra, B L Hulshizer, D F McComsey, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1993
Molecular basis for the inhibition of human alpha-thrombin by the macrocyclic peptide cyclotheonamide AB E Maryanoff, X Qiu, K P Padmanabhan, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|April 4, 1998
Characterization of protease-activated receptor-2 immunoreactivity in normal human tissuesM R D'Andrea, C K Derian, D Leturcq, et al.
Journal of Medicinal Chemistry|May 12, 1995
Design and evaluation of nonpeptide fibrinogen gamma-chain based GPIIb/IIIa antagonistsW J Hoekstra, M P Beavers, P Andrade-Gordon, et al.
Thrombosis Research|October 24, 2001
Antiplatelet and antithrombotic activity of RWJ-53308, a novel orally active glycoprotein IIb/IIIa antagonistB P Damiano, J A Mitchell, E Giardino, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Proceedings of the National Academy of Sciences of the United States of America|September 26, 1995
Evidence for the presence of a protease-activated receptor distinct from the thrombin receptor in human keratinocytesR J Santulli, C K Derian, A L Darrow, et al.
Bioorganic & Medicinal Chemistry Letters|August 22, 2001
Thrombin receptor (PAR-1) antagonists. Solid-phase synthesis of indole-based peptide mimetics by anchoring to a secondary amideH C Zhang, D F McComsey, K B White, et al.
Blood|November 10, 1998
Protease-activated receptor 1 (PAR-1) is required and rate-limiting for thrombin-enhanced experimental pulmonary metastasisM L Nierodzik, K Chen, K Takeshita, et al.
Bioorganic & Medicinal Chemistry Letters|September 12, 2001
1,2,4-triazolo[3,4-a]pyridine as a novel, constrained template for fibrinogen receptor (GPIIb/IIIa) antagonistsE C Lawson, W J Hoekstra, M F Addo, et al.
Archives of Biochemistry and Biophysics|May 23, 2001
Protease-activated receptor-2 (PAR-2): structure-function study of receptor activation by diverse peptides related to tethered-ligand epitopesB E Maryanoff, R J Santulli, D F McComsey, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Thrombin receptor (PAR-1) antagonists. Heterocycle-based peptidomimetics of the SFLLR agonist motifW J Hoekstra, B L Hulshizer, D F McComsey, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1993
Molecular basis for the inhibition of human alpha-thrombin by the macrocyclic peptide cyclotheonamide AB E Maryanoff, X Qiu, K P Padmanabhan, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|April 4, 1998
Characterization of protease-activated receptor-2 immunoreactivity in normal human tissuesM R D'Andrea, C K Derian, D Leturcq, et al.
Journal of Medicinal Chemistry|May 12, 1995
Design and evaluation of nonpeptide fibrinogen gamma-chain based GPIIb/IIIa antagonistsW J Hoekstra, M P Beavers, P Andrade-Gordon, et al.
Thrombosis Research|October 24, 2001
Antiplatelet and antithrombotic activity of RWJ-53308, a novel orally active glycoprotein IIb/IIIa antagonistB P Damiano, J A Mitchell, E Giardino, et al.
Pageof 6